Cite
HARVARD Citation
Royle, K. et al. (2022). Risk and response adapted therapy following autologous stem cell transplant in patients with newly diagnosed multiple myeloma (RADAR (UK-MRA Myeloma XV Trial): study protocol for a phase II/III randomised controlled trial. BMJ open. 12 (11), p. . [Online].